EBANGA
These highlights do not include all the information needed to use EBANGA™ safely and effectively. See full prescribing information for EBANGA. EBANGA (ansuvimab-zykl) for injection, for intravenous use Initial U.S. Approval: 2020
Approved
Approval ID
9c008384-379d-48d3-b5a5-9809ed0f655c
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 23, 2022
Manufacturers
FDA
Ridgeback Biotherapeutics, LP
DUNS: 116921498
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ANSUVIMAB
PRODUCT DETAILS
NDC Product Code80673-777
Application NumberBLA761172
Marketing CategoryC73585
Route of AdministrationN/A
Effective DateMay 23, 2022
Generic NameANSUVIMAB